SHORT BOWEL SYNDROME
Clinical trials for SHORT BOWEL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SHORT BOWEL SYNDROME trials appear
Sign up with your email to follow new studies for SHORT BOWEL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug teduglutide monitored in 250 patients with short bowel syndrome
Disease control OngoingThis study follows 250 people in Japan with short bowel syndrome who are receiving teduglutide (Revestive) injections. Researchers will monitor side effects and how well the drug controls symptoms over 36 months. The goal is to see if teduglutide can safely reduce the need for in…
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New weekly shot shows promise for gut disorder patients
Disease control OngoingThis study tests the long-term safety and effectiveness of a weekly injection called glepaglutide in adults with short bowel syndrome, a condition where the body cannot absorb nutrients properly. Participants who completed a previous trial will receive the drug for about 2 years.…
Matched conditions: SHORT BOWEL SYNDROME
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug could help people with short bowel syndrome ditch IV nutrition
Disease control OngoingThis phase 3 trial tests the long-term safety of glepaglutide, a drug that mimics a natural gut hormone, in 145 adults with short bowel syndrome. The goal is to see if it can safely help the gut absorb more nutrients, potentially reducing the need for intravenous feeding. Partici…
Matched conditions: SHORT BOWEL SYNDROME
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New device could help kids with short bowel syndrome rely less on IV nutrition
Disease control ENROLLING_BY_INVITATIONThis study looks at a device called RELiZORB that attaches to a feeding tube to pre-digest fat, making it easier for children with short bowel syndrome to absorb nutrients. The goal is to see if using it daily for 90 days can safely reduce or eliminate the need for intravenous (I…
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New program aims to ease burden on families of kids with rare diseases
Symptom relief ENROLLING_BY_INVITATIONThis study tests a program called FACE-Rare, designed to support family caregivers of children with rare, life-limiting diseases. The program includes three sessions to help families prepare for future medical decisions and improve their quality of life. Researchers will compare …
Matched conditions: SHORT BOWEL SYNDROME
Phase: NA • Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Global registry tracks Real-World safety of gut drug
Knowledge-focused OngoingThis registry follows about 1,800 people with short bowel syndrome (SBS) to see how safe and effective the drug teduglutide is over the long term in everyday medical practice. It includes both patients who take teduglutide and those who do not. The main goal is to monitor for col…
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Shire • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC